The Mylan N.V. (MYL) Short Interest Down 12.1% in December

The Mylan N.V. (MYL) Short Interest Down 12.1% in December

Mylan N.V. (NASDAQ:MYL) was the target of a large decline in short interest in December. As of December 30th, there was short interest totalling 21,088,901 shares, a decline of 12.1% from the December 15th total of 24,000,135 shares. Based on an average trading volume of 4,030,471 shares, the days-to-cover ratio is currently 5.2 days. Currently, 4.8% of the company’s stock are sold short. Mylan N.V. (NASDAQ:MYL) opened at 36.73 on Friday. The firm has a market capitalization of $19.65 billion, a price-to-earnings ratio of 73.61 and a beta of 1.09….

The Brokerages Set Flexion Therapeutics, Inc. (FLXN) PT at $27.17

The Brokerages Set Flexion Therapeutics, Inc. (FLXN) PT at $27.17

Shares of Flexion Therapeutics, Inc. (NASDAQ:FLXN) have earned an average recommendation of “Buy” from the eleven research firms that are covering the company. One equities research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $27.82. Several research firms have weighed in on FLXN. Zacks Investment Research lowered shares of Flexion Therapeutics from a…

The Cantor Fitzgerald Comments on Axsome Therapeutics, Inc.’s FY2016 Earnings (AXSM)

The Cantor Fitzgerald Comments on Axsome Therapeutics, Inc.’s FY2016 Earnings (AXSM)

Axsome Therapeutics, Inc. (NASDAQ:AXSM) – Investment analysts at Cantor Fitzgerald issued their FY2016 earnings per share estimates for Axsome Therapeutics in a report released on Tuesday. Cantor Fitzgerald analyst C. Russo expects that the firm will post earnings of ($1.43) per share for the year. Cantor Fitzgerald has a “Buy” rating and a $13.00 price target on the stock. Cantor Fitzgerald also issued estimates for Axsome Therapeutics’ FY2017 earnings at ($1.79) EPS. A number of other equities analysts also recently issued reports on AXSM. Zacks Investment Research downgraded Axsome Therapeutics…

The Party City Holdco Inc. (PRTY) Rating Increased to Hold at Zacks Investment Research

The Party City Holdco Inc. (PRTY) Rating Increased to Hold at Zacks Investment Research

Party City Holdco Inc. (NYSE:PRTY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Saturday. According to Zacks, “Party City Holdco Inc. is involved in designs, manufactures, contracts for manufacture and distributes party goods, including paper and plastic tableware, metallic and latex balloons, Halloween and other costumes, accessories, novelties, gifts and stationery. It also operates specialty retail party supply stores primarily in the United States and Canada. Party City Holdco Inc. is based in Elmsford, New York. “…

The Zacks: AC Immune SA (ACIU) Given Consensus Rating of “Strong Buy” by Brokerages

The Zacks: AC Immune  SA (ACIU) Given Consensus Rating of “Strong Buy” by Brokerages

AC Immune SA (NASDAQ:ACIU) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy recommendation. Analysts have set a 1 year consensus target price of $23.00 for the company and are expecting that the company will post ($0.20) EPS for the current quarter, according to Zacks. Zacks has also given AC Immune SA an industry rank of 68 out of 265 based on the ratings…

The FY2016 EPS Estimates for ZELTIQ Aesthetics, Inc. Raised by Leerink Swann (ZLTQ)

The FY2016 EPS Estimates for ZELTIQ Aesthetics, Inc. Raised by Leerink Swann (ZLTQ)

ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) – Equities research analysts at Leerink Swann increased their FY2016 earnings per share (EPS) estimates for ZELTIQ Aesthetics in a research note issued on Tuesday. Leerink Swann analyst R. Newitter now forecasts that the firm will post earnings of ($0.07) per share for the year, up from their previous estimate of ($0.08). Leerink Swann also issued estimates for ZELTIQ Aesthetics’ Q1 2017 earnings at ($0.12) EPS. A number of other analysts have also weighed in on the stock. Maxim Group upped their target price on shares…

The Community Health Systems, Inc. (CYH) Debt Trading 1.8% Higher

The Community Health Systems, Inc. (CYH) Debt Trading 1.8% Higher

An issue of Community Health Systems, Inc. (NYSE:CYH) debt rose 1.8% against its face value during trading on Thursday. The high-yield issue of debt has a 7.125% coupon and is set to mature on July 15, 2020. The debt is now trading at $83.00 and was trading at $81.25 one week ago. Price changes in a company’s debt in credit markets sometimes anticipate parallel changes in its stock price. Several brokerages recently weighed in on CYH. Citigroup Inc. set a $12.00 target price on shares of Community Health Systems and…

The Marc Grondahl Sells 94,289 Shares of Planet Fitness, Inc. (PLNT) Stock

The Marc Grondahl Sells 94,289 Shares of Planet Fitness, Inc. (PLNT) Stock

Planet Fitness, Inc. (NYSE:PLNT) Director Marc Grondahl sold 94,289 shares of the firm’s stock in a transaction dated Wednesday, January 11th. The shares were sold at an average price of $20.47, for a total value of $1,930,095.83. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Marc Grondahl also recently made the following trade(s): Shares of Planet Fitness, Inc. (NYSE:PLNT) opened at 20.68 on Friday. Planet Fitness, Inc. has a 12-month low of $13.23 and a 12-month high of $25.10. The firm’s 50-day…

The Glen Burnie Bancorp (GLBZ) to Issue Quarterly Dividend of $0.10 on February 3rd

The Glen Burnie Bancorp (GLBZ) to Issue Quarterly Dividend of $0.10 on  February 3rd

Glen Burnie Bancorp (NASDAQ:GLBZ) declared a quarterly dividend on Thursday, January 12th. Investors of record on Monday, January 23rd will be paid a dividend of 0.10 per share by the financial services provider on Friday, February 3rd. This represents a $0.40 dividend on an annualized basis and a dividend yield of 3.43%. The ex-dividend date of this dividend is Thursday, January 19th. Glen Burnie Bancorp (NASDAQ:GLBZ) opened at 11.6629 on Friday. The company has a 50 day moving average price of $11.05 and a 200-day moving average price of $10.59….

The Zacks: Berkshire Hills Bancorp, Inc. (BHLB) Given $32.25 Average Price Target by Analysts

The Zacks: Berkshire Hills Bancorp, Inc. (BHLB) Given $32.25 Average Price Target by Analysts

Shares of Berkshire Hills Bancorp, Inc. (NASDAQ:BHLB) have been given a consensus broker rating score of 3.50 (Sell) from the four analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong sell recommendation and three have given a hold recommendation to the company. Berkshire Hills Bancorp’s rating score has declined by 25% from 90 days ago as a result of a number of analysts’ ratings changes. Brokers have set a one year consensus price objective of $32.25 for the company and…

The LGI Homes, Inc. (LGIH) Receives $35.50 Average Price Target from Brokerages

The LGI Homes, Inc. (LGIH) Receives $35.50 Average Price Target from Brokerages

LGI Homes, Inc. (NASDAQ:LGIH) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the company. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $35.50. A number of equities research analysts have weighed in on the company. Zacks Investment Research raised LGI Homes from a “sell” rating to a “hold”…

The The Finish Line, Inc. (FINL) Sees Significant Drop in Short Interest

The The Finish Line, Inc. (FINL) Sees Significant Drop in Short Interest

The Finish Line, Inc. (NASDAQ:FINL) was the recipient of a large drop in short interest during the month of December. As of December 30th, there was short interest totalling 8,589,295 shares, a drop of 26.8% from the December 15th total of 11,737,590 shares. Currently, 21.6% of the shares of the company are short sold. Based on an average daily volume of 3,313,574 shares, the days-to-cover ratio is presently 2.6 days. In related news, Director Glenn S. Lyon sold 75,000 shares of The Finish Line stock in a transaction dated Thursday,…

The Navient Corporation (NAVI) Short Interest Down 11.5% in December

The Navient Corporation (NAVI) Short Interest Down 11.5% in December

Navient Corporation (NASDAQ:NAVI) saw a large decrease in short interest in the month of December. As of December 30th, there was short interest totalling 15,917,543 shares, a decrease of 11.5% from the December 15th total of 17,987,674 shares. Currently, 5.3% of the shares of the stock are sold short. Based on an average trading volume of 2,997,402 shares, the short-interest ratio is presently 5.3 days. Large investors have recently made changes to their positions in the company. Thrivent Financial for Lutherans purchased a new stake in shares of Navient Corporation…

The easyJet plc (EZJ) Receives GBX 1,279.23 Consensus Target Price from Analysts

The easyJet plc (EZJ) Receives GBX 1,279.23 Consensus Target Price from Analysts

easyJet plc (LON:EZJ) has earned a consensus recommendation of “Hold” from the twenty-seven brokerages that are presently covering the firm. Four investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 1,238.55 ($15.06). A number of equities analysts recently weighed in on EZJ shares. Goldman Sachs Group, Inc. (The) restated a “buy”…

The Zacks Investment Research Downgrades Recro Pharma, Inc. (REPH) to Sell

The Zacks Investment Research Downgrades Recro Pharma, Inc. (REPH) to Sell

Recro Pharma, Inc. (NASDAQ:REPH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Saturday. According to Zacks, “Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain…

The American Capital Senior Floating, Ltd. (ACSF) Announces Dividend of $0.10

The American Capital Senior Floating, Ltd. (ACSF) Announces Dividend of $0.10

American Capital Senior Floating, Ltd. (NASDAQ:ACSF) declared a dividend on Friday, November 4th. Investors of record on Monday, January 23rd will be paid a dividend of 0.097 per share on Thursday, February 2nd. The ex-dividend date of this dividend is Thursday, January 19th. American Capital Senior Floating (NASDAQ:ACSF) opened at 12.745 on Friday. American Capital Senior Floating has a 12 month low of $7.86 and a 12 month high of $12.85. The company has a 50-day moving average of $11.86 and a 200-day moving average of $11.10. In related news,…

The Wal-Mart Stores’ (WMT) “Sell” Rating Reiterated at Brean Capital

The Wal-Mart Stores’ (WMT) “Sell” Rating Reiterated at Brean Capital

Wal-Mart Stores, Inc. (NYSE:WMT)‘s stock had its “sell” rating reissued by equities researchers at Brean Capital in a research note issued on Friday. They currently have a $62.00 price objective on the retailer’s stock. Brean Capital’s price objective would suggest a potential downside of 7.64% from the company’s previous close. Other equities research analysts have also issued reports about the stock. Barclays PLC reaffirmed an “overweight” rating and issued a $82.00 price objective on shares of Wal-Mart Stores in a research note on Sunday, November 13th. Goldman Sachs Group, Inc….

The Morgan Stanley (MS) Rating Reiterated by CLSA

The Morgan Stanley (MS) Rating Reiterated by CLSA

Morgan Stanley (NYSE:MS)‘s stock had its “buy” rating reaffirmed by CLSA in a report released on Friday. They currently have a $54.00 target price on the financial services provider’s stock. CLSA’s target price would indicate a potential upside of 23.26% from the stock’s current price. MS has been the topic of several other reports. Citigroup Inc. increased their target price on shares of Morgan Stanley from $30.00 to $32.00 and gave the stock a “neutral” rating in a report on Monday, October 10th. Barclays PLC increased their target price on…

The Wells Fargo & Company (WFC) Receives “Outperform” Rating from CLSA

The Wells Fargo & Company (WFC) Receives “Outperform” Rating from CLSA

Wells Fargo & Company (NYSE:WFC)‘s stock had its “outperform” rating reissued by research analysts at CLSA in a report released on Friday. They presently have a $64.00 price objective on the financial services provider’s stock. CLSA’s price objective would suggest a potential upside of 15.71% from the stock’s previous close. A number of other analysts have also recently issued reports on the company. Evercore ISI reissued a “buy” rating and issued a $51.00 target price on shares of Wells Fargo & Company in a research report on Sunday, October 23rd….

The Shore Capital Reaffirms Buy Rating for Zoopla Property Group PLC (ZPLA)

The Shore Capital Reaffirms Buy Rating for Zoopla Property Group PLC (ZPLA)

Zoopla Property Group PLC (LON:ZPLA)‘s stock had its “buy” rating reaffirmed by stock analysts at Shore Capital in a note issued to investors on Friday. Several other equities research analysts have also issued reports on the stock. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a GBX 301 ($3.66) target price on shares of Zoopla Property Group PLC in a report on Friday. Berenberg Bank restated a “buy” rating and issued a GBX 400 ($4.86) price target on shares of Zoopla Property Group PLC in a research…